Corporations are going to use IP law to profit from psychedelics. But creative strategies from other industries could help people push back against exclusionary ownership and keep drugs accessible.
Corporations are going to use IP law to profit from psychedelics. But creative
strategies from other industries could help people push back against
exclusionary ownership and keep drugs accessible.
A review confirming what has long been known is being used to make misleading claims about antidepressants—and shows the gap between scientific knowledge and public understanding.